The Kenya BioVax Institute was established in 2021 to manufacture and commercialize human vaccines and other health products and technologies.
Featured Articles
On the Path to Production: BioVax Board Inspects Progress at Embakasi Facility
The Chairman of the Board of Directors, Dr. Charles Githinji, led members of the Kenya BioVax Institute Limited Board on an inspection visit to the Embakasi manufacturing site to assess the ongoing enabling works and overall project progress. Accompanied by...
"The journey to vaccine self-reliance is a national priority that demands unwavering collaboration. At Kenya BioVax, we are committed to accelerating this mission, partnering with global leaders and local experts to turn the promise of health security into a tangible reality for all Kenyans."
Dr. Wesley Ronoh, Director General/Chief Executive OfficerKenya BioVax Institute, Nairobi.
